GL1X · GenesisL1 explorer

UniProt P30613

Pyruvate kinase PKLR (P30613)

Pyruvate kinase PKLR (UniProt P30613), EC 2.7.1.40: 36 experimental structures on GenesisL1, 26 ligands bound, 360 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
P30613
Protein
Pyruvate kinase PKLR
EC
2.7.1.40
Experimental structures
36
Predicted models
0
Ligands
26
Pockets
360 · 18 records with a druggable one

Structures

36 records of P30613 in the MolNFT archive: 36 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
2VGBHuman erythrocyte pyruvate kinasex-ray diffractionA, B, C, D——
2VGBHuman erythrocyte pyruvate kinasex-ray diffractionA, B, C, D——
2VGFHUMAN ERYTHROCYTE PYRUVATE KINASE: T384M mutantx-ray diffractionA, B, C, D——
2VGFHuman erythrocyte pyruvate kinase: T384M mutantx-ray diffractionA, B, C, D——
2VGGHuman erythrocyte pyruvate kinase: R479H mutantx-ray diffractionA, B, C, D——
2VGGHuman erythrocyte pyruvate kinase: R479H mutantx-ray diffractionA, B, C, D——
2VGIHuman erythrocyte pyruvate kinase: R486W mutantx-ray diffractionA, B, C, D——
2VGIHuman erythrocyte pyruvate kinase: R486W mutantx-ray diffractionA, B, C, D——
4IP7Structure of the S12D variant of human liver pyruvate kinase in complex with citrate and FBP.x-ray diffractionA, B, C, D——
4IP7Structure of the S12D variant of human liver pyruvate kinase in complex with citrate and fbp.x-ray diffractionA, B, C, D——
6NN4The structure of human liver pyruvate kinase, hlpyk-D499N, in complex with fru-1,6-bpx-ray diffractionA, B, C, DFBP, PEP—
6NN5The structure of human liver pyruvate kinase, hlpyk-W527Hx-ray diffractionA, B, C, D——
6NN7The structure of human liver pyruvate kinase, hLPYK-GGGx-ray diffractionA, B, C, E, D, F, G, H—20 (best 0.87)
6NN7The structure of human liver pyruvate kinase, hlpyk-gggx-ray diffractionA, B, C, E, D, F, G, H——
6NN8The structure of human liver pyruvate kinase, hLPYK-S531Ex-ray diffractionA, B, C, D, E, F, G, H—20 (best 0.88)
6NN8The structure of human liver pyruvate kinase, hlpyk-S531Ex-ray diffractionA, B, C, D, E, F, G, H——
7FRVStructure of liver pyruvate kinase in complex with allosteric modulator 3x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, OD5—
7FRWStructure of liver pyruvate kinase in complex with allosteric modulator 4x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, OA020 (best 0.88)
7FRXStructure of liver pyruvate kinase in complex with allosteric modulator 5x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, O8820 (best 0.87)
7FRYStructure of liver pyruvate kinase in complex with allosteric modulator 6x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, Y0T20 (best 0.88)
7FRZStructure of liver pyruvate kinase in complex with allosteric modulator 7x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, O9920 (best 0.87)
7FS0Structure of liver pyruvate kinase in complex with allosteric modulator 8x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, O8X20 (best 0.87)
7FS1Structure of liver pyruvate kinase in complex with allosteric modulator 11x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, O8F20 (best 0.87)
7FS2Structure of liver pyruvate kinase in complex with allosteric modulator 13x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, O7X20 (best 0.87)
7FS3Structure of liver pyruvate kinase in complex with allosteric modulator 15x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, O9I20 (best 0.88)
7FS4Structure of liver pyruvate kinase in complex with allosteric modulator 16x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, O9R20 (best 0.88)
7FS5Structure of liver pyruvate kinase in complex with allosteric modulator 17x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, O8O20 (best 0.87)
7FS6Structure of liver pyruvate kinase in complex with allosteric modulator 18x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, Y3Z20 (best 0.88)
7FS9Structure of liver pyruvate kinase in complex with allosteric modulator 22x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, OB020 (best 0.87)
7FSBStructure of liver pyruvate kinase in complex with allosteric modulator 41x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, OE0—
7FSCStructure of liver pyruvate kinase in complex with allosteric modulator 42x-ray diffractionA, B, C, D, E, F, G, HFBP, OXL, MG, K, ODL20 (best 0.87)
7QDNStructure of human liver pyruvate kinase from which the B domain has been deletedx-ray diffractionA, B, C, D, E, F, G, HFBP, OXD, MG, K, NA20 (best 0.87)
7QDNStructure of human liver pyruvate kinase from which the B domain has been deletedx-ray diffractionA, B, C, D, E, F, G, HFBP, OXD, MG, K, NA—
8TBSStructure of human erythrocyte pyruvate kinase in complex with an allosteric activator AG-946x-ray diffractionA, B, C, D, E, F, G, HFBP, MN, K, PYR, HVI20 (best 0.89)
8TBUStructure of human erythrocyte pyruvate kinase in complex with an allosteric activator Compound 12x-ray diffractionA, B, C, D, E, F, G, HI0R, PYR, FBP, MN, K20 (best 0.89)
P30613AlphaFold monomer V2.0 prediction for pyruvate kinase pklr (P30613)———

Ligands

  • FBP · 1,6-di-O-phosphono-beta-D-fructofuranose · in 20 records
  • K · Potassium ion · in 19 records
  • MG · Magnesium ion · in 17 records
  • OXL · Oxalate ion · in 15 records
  • MN · Manganese (II) ion · in 2 records
  • NA · Sodium ion · in 2 records
  • OXD · Oxalic acid · in 2 records
  • PYR · Pyruvic acid · in 2 records
  • HVI · 6-[(6-aminopyridin-2-yl)methyl]-4-methyl-2-[(1H-pyrazol-3-yl)methyl]-4,6-dihydro-5H-[1,3]thiazolo[5',4':4,5]pyrrolo[2,3-d]pyridazin-5-one · in 1 record
  • I0R · 6-[(4-hydroxyphenyl)methyl]-2,4-dimethyl-4,6-dihydro-5H-[1,3]thiazolo[5',4':4,5]pyrrolo[2,3-d]pyridazin-5-one · in 1 record
  • O7X · (1P)-3',4,4',5-tetrahydroxy-N-{[4-(3-hydroxybenzene-1-sulfonyl)phenyl]methyl}[1,1'-biphenyl]-2-sulfonamide · in 1 record
  • O88 · N-{[4-(3,4-dihydroxybenzene-1-sulfonyl)phenyl]methyl}-3,4-dihydroxybenzene-1-sulfonamide · in 1 record
  • O8F · (1P)-N-{[4-(3,4-dihydroxybenzene-1-sulfonyl)phenyl]methyl}-3',4,4',5-tetrahydroxy[1,1'-biphenyl]-2-sulfonamide · in 1 record
  • O8O · (10aP)-6-{[4-(3,4-dihydroxybenzene-1-sulfonyl)phenyl]methyl}-2,3,8,9-tetrahydroxy-5lambda~6~-dibenzo[c,e][1,2]thiazine-5,5(6H)-dione · in 1 record
  • O8X · 3,4-dihydroxy-N-{2-[4-(3-hydroxybenzene-1-sulfonyl)phenyl]ethyl}benzene-1-sulfonamide · in 1 record
  • O99 · 3,4-dihydroxy-N-{[4-(3-hydroxybenzene-1-sulfonyl)phenyl]methyl}benzene-1-sulfonamide · in 1 record
  • O9I · N-{[4-(3,4-dihydroxybenzene-1-sulfonyl)phenyl]methyl}-4,4',5-trihydroxy[1,1'-biphenyl]-2-sulfonamide · in 1 record
  • O9R · 4,4',5-trihydroxy-N-{[4-(3-hydroxybenzene-1-sulfonyl)phenyl]methyl}[1,1'-biphenyl]-2-sulfonamide · in 1 record
  • OA0 · (10aM)-3,8,9-trihydroxy-6H-6lambda~6~-dibenzo[c,e][1,2]oxathiine-6,6-dione · in 1 record
  • OB0 · 4-[4-(4-aminobenzene-1-sulfonyl)piperazine-1-sulfonyl]benzene-1,2-diol · in 1 record
  • OD5 · 4,4'-sulfonyldi(benzene-1,2-diol) · in 1 record
  • ODL · N-({4-[(3,4-dihydroxyphenyl)methyl]phenyl}methyl)benzenesulfonamide · in 1 record
  • OE0 · N-({4-[(3,4-dihydroxyphenyl)methyl]phenyl}methyl)-3,4-dihydroxybenzene-1-sulfonamide · in 1 record
  • PEP · Phosphoenolpyruvate · in 1 record
  • Y0T · N-{2-[4-(3,4-dihydroxybenzene-1-sulfonyl)phenyl]ethyl}-3,4-dihydroxybenzene-1-sulfonamide · in 1 record
  • Y3Z · (10aM)-6-{2-[4-(3,4-dihydroxybenzene-1-sulfonyl)phenyl]ethyl}-2,3,8,9-tetrahydroxy-5lambda~6~-dibenzo[c,e][1,2]thiazine-5,5(6H)-dione · in 1 record

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.